Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Dec 15, 2023

Accession no.
0000947871-23-001154
Filed
Dec 15, 2023, 6:04 PM ET
Trade date
Dec 14, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $24.6M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director
OrbiMed Capital GP VI LLCCIK 0001682115Director
OrbiMed Genesis GP LLCCIK 0001808744Director
OrbiMed Capital GP VIII LLCCIK 0001845804Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 14, 2023Common StockSSaleDisposed−228,500$56.75−$12,967,375897,625IndirectDuplicate filing
Dec 14, 2023Common StockSSaleDisposed−147,600$56.75−$8,376,300580,207IndirectDuplicate filing
Dec 14, 2023Common StockSSaleDisposed−57,100$56.75−$3,240,425224,405IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)